Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

Egalet Announces Launch of Specialty Pharmaceutical Sales Force


http://www.prnewswire.com/news-releases/egalet-announces-launch-of-specialty-pharmaceutical-sales-force-300103180.html

The sales force will focus on the top prescribing healthcare providers who prescribe pain medication. Sales representatives will begin making office visits to educate healthcare providers on SPRIX, a non-steroidal anti-inflammatory drug (NSAID) indicated in adult patients for the short-term (up to five days) management of moderate to moderately severe pain that requires analgesia at the opioid level, following the completion of sales training. Promotion of OXAYDO, the first and only approved immediate-release oxycodone product formulated to discourage abuse via snorting, will begin by the end of the third quarter.

Oxaydo is the old Oxecta, which Pfizer returned to Acura and then Acura licensed to Egalet. It never did very well for Pfizer, mostly because it performed poorly in HAL studies but yet cost 20X generic immediate-release oxycodone.




Only 30% of subjects would not want to abuse it again:






20X Price premium for Oxecta:






ELI-200 HAL data is far superior. Makes one wonder how ELI-200 will compare with Oxaydo on price. And two viable ADF immediate-release oxycodone will give FDA an opportunity to fulfill their promise to pull non-ADF generics. Also, too, suppose we'll soon be seeing Epic's PR about their Launch of Specialty Pharmaceutical Sales Force.